ArriVent BioPharma (AVBP) Institutional Ownership $27.25 +0.62 (+2.33%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ArriVent BioPharma (NASDAQ:AVBP)CurrentInstitutional OwnershipPercentage9.48%Number ofInstitutional Buyers(last 12 months)21TotalInstitutional Inflows(last 12 months)$132.18MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.78M Get AVBP Insider Trade Alerts Want to know when executives and insiders are buying or selling ArriVent BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVBP Institutional Buying and Selling by Quarter ArriVent BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/26/2024JPMorgan Chase & Co.12,445$292K0.0%+183.2%0.037% 11/19/2024Barclays PLC41,522$976K0.0%+1,124.8%0.123% 11/16/2024Geode Capital Management LLC597,165$14.04M0.0%+154.2%1.778% 11/15/2024Barclays PLC41,522$976K0.0%+1,124.8%0.124% 11/15/2024Jane Street Group LLC10,626$250K0.0%-30.7%0.032% 11/15/2024State Street Corp476,809$11.21M0.0%+210.4%1.419% 11/14/2024Suvretta Capital Management LLC1,845,162$43.36M1.4%+7.7%5.493% 11/14/2024MetLife Investment Management LLC16,350$384K0.0%+168.9%0.049% 11/13/2024BNP Paribas Financial Markets21,965$516K0.0%+32.6%0.065% 11/13/2024FMR LLC2,119,695$49.81M0.0%+8.7%6.310% Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024The Manufacturers Life Insurance Company10,234$240K0.0%N/A0.030% 11/12/2024Charles Schwab Investment Management Inc.202,368$4.76M0.0%+153.8%0.602% 10/30/2024AlphaCentric Advisors LLC15,000$352K0.3%-82.6%0.045% 10/24/2024Novo Holdings A S1,505,315$35.38M1.8%+0.4%4.494% 10/3/2024 SG Americas Securities LLC11,927$280K0.0%N/A0.036% 8/20/2024Novo Holdings A S1,500,000$27.83M1.4%+39.3%4.478% 8/1/2024Rhumbline Advisers12,707$236K0.0%+30.1%0.038% 7/26/2024Bank of New York Mellon Corp29,847$554K0.0%+31.4%0.089% 7/26/2024AlphaCentric Advisors LLC86,000$1.60M1.2%+3.6%0.257% 5/24/2024Farallon Capital Management LLC151,768$2.71M0.0%N/A0.453% 5/16/2024Blackstone Inc.25,000$446K0.0%N/A0.075% 5/15/2024Hhlr Advisors LTD.3,929,117$70.17M1.5%N/A11.732% 5/15/2024Altitude Crest Partners Inc.555,555$9.92M4.2%N/A1.659% 5/14/2024American International Group Inc.4,845$87K0.0%N/A0.014% 5/10/2024Vanguard Group Inc.648,735$11.59M0.0%N/A1.937% 5/1/2024BNP Paribas Financial Markets4,659$83K0.0%N/A0.014% (Data available from 1/1/2016 forward) AVBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVBP shares? During the previous two years, 22 institutional investors and hedge funds held shares of ArriVent BioPharma. The most heavily invested institutionals were Hhlr Advisors LTD. ($70.17M), FMR LLC ($49.81M), Suvretta Capital Management LLC ($43.36M), Novo Holdings A S ($35.38M), Geode Capital Management LLC ($14.04M), Vanguard Group Inc. ($11.59M), and State Street Corp ($11.21M).Learn more on AVBP's institutional investors. What percentage of ArriVent BioPharma stock is owned by institutional investors? 9.48% of ArriVent BioPharma stock is owned by institutional investors. Learn more on AVBP's institutional investor holdings. Which institutional investors have been buying ArriVent BioPharma stock? Of the 21 institutional investors that purchased ArriVent BioPharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hhlr Advisors LTD. ($3.93M), Vanguard Group Inc. ($648.74K), Altitude Crest Partners Inc. ($555.56K), Novo Holdings A S ($428.18K), Geode Capital Management LLC ($362.22K), State Street Corp ($323.19K), and FMR LLC ($169.51K). How much institutional buying is happening at ArriVent BioPharma? Institutional investors have bought a total of 6,993,098 shares in the last 24 months. This purchase volume represents approximately $132.18M in transactions. Which ArriVent BioPharma major shareholders have been selling company stock? The following institutional investors have sold ArriVent BioPharma stock in the last 24 months: AlphaCentric Advisors LLC ($71K), and Jane Street Group LLC ($4.71K). How much institutional selling is happening at ArriVent BioPharma? Institutional investors have sold a total of 75,707 shares in the last 24 months. This volume of shares sold represents approximately $1.78M in transactions. Related Companies PTC Therapeutics Institutional Ownership Avidity Biosciences Institutional Ownership Rhythm Pharmaceuticals Institutional Ownership Immunovant Institutional Ownership ACADIA Pharmaceuticals Institutional Ownership Vericel Institutional Ownership Xenon Pharmaceuticals Institutional Ownership MoonLake Immunotherapeutics Institutional Ownership MorphoSys Institutional Ownership Denali Therapeutics Institutional Ownership This page (NASDAQ:AVBP) was last updated on 1/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
